Literature DB >> 10947855

Interaction of dendritic cells with mycobacteria: where the action starts.

C Demangel1, W J Britton.   

Abstract

Dendritic cells (DC) are the major antigen-presenting cells in the induction of cellular responses to intracellular pathogens, such as mycobacteria. Recent studies have shown that they also play a critical role in the regulation of immune responses. The interaction of DC with microbial antigens may be the controlling factor in the development of a Th1-orientated protective immunity. Analysis of the innate response of DC to mycobacteria and the involvement of the DC receptors in antigen recognition have highlighted the pivotal role of these cells in T-cell activation. Mycobacteria-infected DC have an enhanced capacity to release pro-inflammatory cytokines and chemokines and are potent inducers of interferon-gamma-producing cells in vivo. Therefore, DC manipulation for maximal antigen presentation and Th1 cytokine production may form the basis of a new generation of vaccines, with improved efficacy against mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947855     DOI: 10.1046/j.1440-1711.2000.00935.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  25 in total

1.  Phagocytosis of bacille Calmette-Guérin-infected necrotic macrophages induces a maturation phenotype and evokes antigen-presentation functions in dendritic cells.

Authors:  Oliver Goldmann; Manfred Rohde; Eva Medina
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Identification and analysis of exosomes secreted from macrophages extracted by different methods.

Authors:  Jianjun Wang; Yongliang Yao; Jianhong Wu; Guangxin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.

Authors:  Wei Chen; Yige Bao; Xuerong Chen; Jeremy Burton; Xueli Gong; Dongqing Gu; Youjun Mi; Lang Bao
Journal:  Med Microbiol Immunol       Date:  2015-08-30       Impact factor: 3.402

4.  Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

Authors:  Teresa M Wozniak; Anthony A Ryan; James A Triccas; Warwick J Britton
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.

Authors:  Kun Taek Park; Andrew J Allen; John P Bannantine; Keun Seok Seo; Mary J Hamilton; Gaber S Abdellrazeq; Heba M Rihan; Amanda Grimm; William C Davis
Journal:  Vaccine       Date:  2011-05-10       Impact factor: 3.641

Review 6.  Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue.

Authors:  William C Davis; Sally A Madsen-Bouterse
Journal:  Vet Immunol Immunopathol       Date:  2011-12-14       Impact factor: 2.046

7.  Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis.

Authors:  Q Tan; W P Xie; R Min; G Q Dai; C-C Xu; H Q Pan; C D Miao; Z Yang; W G Xu; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

8.  Lupus and leprosy: beyond the coincidence.

Authors:  F M Ribeiro; V E Gomez; E M N Albuquerque; E M Klumb; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

9.  Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN.

Authors:  Nicole N Driessen; Roy Ummels; Janneke J Maaskant; Sudagar S Gurcha; Gurdyal S Besra; Gary D Ainge; David S Larsen; Gavin F Painter; Christina M J E Vandenbroucke-Grauls; Jeroen Geurtsen; Ben J Appelmelk
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

10.  Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale.

Authors:  Sushan Han; Junzo Norimine; Guy H Palmer; Waithaka Mwangi; Kevin K Lahmers; Wendy C Brown
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.